1. Home
  2. OTLK vs HOUR Comparison

OTLK vs HOUR Comparison

Compare OTLK & HOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OTLK
  • HOUR
  • Stock Information
  • Founded
  • OTLK 2010
  • HOUR 2015
  • Country
  • OTLK United States
  • HOUR United States
  • Employees
  • OTLK N/A
  • HOUR N/A
  • Industry
  • OTLK Biotechnology: Biological Products (No Diagnostic Substances)
  • HOUR Catalog/Specialty Distribution
  • Sector
  • OTLK Health Care
  • HOUR Consumer Discretionary
  • Exchange
  • OTLK Nasdaq
  • HOUR Nasdaq
  • Market Cap
  • OTLK 48.3M
  • HOUR 47.1M
  • IPO Year
  • OTLK 2016
  • HOUR 2022
  • Fundamental
  • Price
  • OTLK $1.57
  • HOUR $1.59
  • Analyst Decision
  • OTLK Strong Buy
  • HOUR
  • Analyst Count
  • OTLK 5
  • HOUR 0
  • Target Price
  • OTLK $9.60
  • HOUR N/A
  • AVG Volume (30 Days)
  • OTLK 796.7K
  • HOUR 396.0K
  • Earning Date
  • OTLK 08-13-2025
  • HOUR 08-08-2025
  • Dividend Yield
  • OTLK N/A
  • HOUR N/A
  • EPS Growth
  • OTLK N/A
  • HOUR N/A
  • EPS
  • OTLK 0.83
  • HOUR 0.01
  • Revenue
  • OTLK N/A
  • HOUR $139,408,829.00
  • Revenue This Year
  • OTLK N/A
  • HOUR N/A
  • Revenue Next Year
  • OTLK $379.84
  • HOUR N/A
  • P/E Ratio
  • OTLK $1.91
  • HOUR $204.11
  • Revenue Growth
  • OTLK N/A
  • HOUR 2.71
  • 52 Week Low
  • OTLK $0.87
  • HOUR $0.83
  • 52 Week High
  • OTLK $9.25
  • HOUR $6.90
  • Technical
  • Relative Strength Index (RSI)
  • OTLK 40.37
  • HOUR 65.29
  • Support Level
  • OTLK $1.65
  • HOUR $1.31
  • Resistance Level
  • OTLK $2.04
  • HOUR $1.53
  • Average True Range (ATR)
  • OTLK 0.12
  • HOUR 0.15
  • MACD
  • OTLK -0.03
  • HOUR 0.02
  • Stochastic Oscillator
  • OTLK 2.13
  • HOUR 39.80

About OTLK Outlook Therapeutics Inc.

Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

About HOUR Hour Loop Inc.

Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).

Share on Social Networks: